ReviewFrontiers in immunology2026

The NLRP3 inflammasome in metabolic dysfunction-associated steatotic liver disease: role and advances in therapeutic targeting.

Sheng Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.